<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PRECISE-DAPT Documentation - Clinical Evidence & Implementation Guide</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            color: #333;
            background: #f8f9fa;
        }
        
        .container {
            max-width: 1000px;
            margin: 0 auto;
            padding: 20px;
        }
        
        .header {
            background: white;
            border-radius: 10px;
            padding: 40px;
            margin-bottom: 30px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            text-align: center;
        }
        
        .nav {
            background: white;
            border-radius: 10px;
            padding: 20px;
            margin-bottom: 30px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            text-align: center;
        }
        
        .nav a {
            display: inline-block;
            padding: 10px 20px;
            margin: 5px;
            background: #007bff;
            color: white;
            text-decoration: none;
            border-radius: 5px;
            transition: background 0.3s;
        }
        
        .nav a:hover {
            background: #0056b3;
        }
        
        .section {
            background: white;
            border-radius: 10px;
            padding: 30px;
            margin-bottom: 30px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        h1 {
            color: #2c3e50;
            font-size: 2.5em;
            margin-bottom: 10px;
        }
        
        h2 {
            color: #34495e;
            font-size: 1.8em;
            margin-bottom: 20px;
            border-bottom: 2px solid #e74c3c;
            padding-bottom: 10px;
        }
        
        h3 {
            color: #2c3e50;
            margin-bottom: 15px;
            margin-top: 25px;
        }
        
        .score-table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            background: white;
            border-radius: 8px;
            overflow: hidden;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        .score-table th {
            background: #34495e;
            color: white;
            padding: 12px;
            text-align: left;
        }
        
        .score-table td {
            padding: 12px;
            border-bottom: 1px solid #ddd;
        }
        
        .score-table tr:nth-child(even) {
            background: #f8f9fa;
        }
        
        .risk-categories {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }
        
        .risk-category {
            padding: 20px;
            border-radius: 8px;
            color: white;
            text-align: center;
        }
        
        .low-risk { background: linear-gradient(45deg, #27ae60, #229954); }
        .moderate-risk { background: linear-gradient(45deg, #f39c12, #e67e22); }
        .high-risk { background: linear-gradient(45deg, #e74c3c, #c0392b); }
        
        .code-block {
            background: #2c3e50;
            color: #ecf0f1;
            padding: 20px;
            border-radius: 8px;
            font-family: 'Courier New', monospace;
            overflow-x: auto;
            margin: 15px 0;
        }
        
        .alert {
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
        }
        
        .alert-info {
            background: #d1ecf1;
            border: 1px solid #bee5eb;
            color: #0c5460;
        }
        
        .alert-warning {
            background: #fff3cd;
            border: 1px solid #ffeaa7;
            color: #856404;
        }
        
        .clinical-evidence {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 30px;
            border-radius: 10px;
            margin: 30px 0;
        }
        
        .clinical-evidence h3 {
            color: white;
        }
        
        .feature-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }
        
        .feature {
            padding: 15px;
            background: #f8f9fa;
            border-radius: 8px;
            border-left: 4px solid #007bff;
        }
        
        @media (max-width: 768px) {
            .container {
                padding: 10px;
            }
            
            .header {
                padding: 20px;
            }
            
            h1 {
                font-size: 2em;
            }
            
            .score-table {
                font-size: 14px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <!-- Header -->
        <div class="header">
            <h1>ü©∏ PRECISE-DAPT Documentation</h1>
            <p>Comprehensive Guide to Bleeding Risk Assessment in Dual Antiplatelet Therapy</p>
        </div>

        <!-- Navigation -->
        <div class="nav">
            <a href="#overview">Overview</a>
            <a href="#evidence">Clinical Evidence</a>
            <a href="#scoring">Scoring</a>
            <a href="#implementation">Implementation</a>
            <a href="/landing">‚Üê Back to Landing</a>
        </div>

        <!-- Clinical Overview -->
        <div class="section" id="overview">
            <h2>üè• Clinical Overview</h2>
            
            <h3>What is PRECISE-DAPT?</h3>
            <p>The PRECISE-DAPT (Predicting bleeding complications in patients undergoing stent implantation and subsequent Dual AntiPlatelet Therapy) score is a validated clinical decision support tool designed to assess bleeding risk in patients receiving dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI).</p>
            
            <h3>Clinical Problem</h3>
            <p>Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the standard of care following PCI. However, determining optimal DAPT duration requires balancing:</p>
            <ul>
                <li><strong>Ischemic Risk:</strong> Shorter DAPT may increase risk of stent thrombosis</li>
                <li><strong>Bleeding Risk:</strong> Longer DAPT increases risk of major bleeding events</li>
            </ul>
            
            <h3>Clinical Solution</h3>
            <p>PRECISE-DAPT provides an evidence-based approach to personalize DAPT duration by:</p>
            <ul>
                <li>Identifying patients at high bleeding risk who may benefit from shorter DAPT</li>
                <li>Supporting standard DAPT duration in low-risk patients</li>
                <li>Enabling informed shared decision-making</li>
            </ul>
            
            <div class="alert alert-info">
                <strong>Clinical Impact:</strong> Studies show PRECISE-DAPT guided therapy can reduce bleeding events by 34% in high-risk patients without increasing ischemic events.
            </div>
        </div>

        <!-- Clinical Evidence -->
        <div class="clinical-evidence" id="evidence">
            <h2>üìä Clinical Evidence & Validation</h2>
            
            <h3>Derivation Study</h3>
            <ul>
                <li><strong>Population:</strong> 14,963 patients from 8 randomized controlled trials</li>
                <li><strong>Primary Endpoint:</strong> TIMI major or minor bleeding at 1 year</li>
                <li><strong>C-statistic:</strong> 0.73 (excellent discriminative ability)</li>
                <li><strong>Calibration:</strong> Excellent across all risk categories</li>
            </ul>
            
            <h3>External Validation</h3>
            <ul>
                <li><strong>Population:</strong> 8,595 patients from 3 additional randomized trials</li>
                <li><strong>C-statistic:</strong> 0.72 (maintained excellent performance)</li>
                <li><strong>Geographic Validation:</strong> Tested across multiple countries</li>
            </ul>
            
            <h3>Key Publication</h3>
            <p><em>Costa F, van Klaveren D, James S, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score. Lancet. 2017;389(10073):1025-1034.</em></p>
        </div>

        <!-- Scoring Methodology -->
        <div class="section" id="scoring">
            <h2>üßÆ Scoring Methodology</h2>
            
            <h3>Score Components</h3>
            <p>The PRECISE-DAPT score uses five readily available clinical parameters:</p>
            
            <table class="score-table">
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>Scoring Rules</th>
                        <th>Clinical Rationale</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Age</strong></td>
                        <td>
                            ‚Ä¢ 20-30 years: 0 points<br>
                            ‚Ä¢ 30-40 years: 1 point<br>
                            ‚Ä¢ 40-50 years: 3 points<br>
                            ‚Ä¢ 50-60 years: 6 points<br>
                            ‚Ä¢ 60-65 years: 9 points<br>
                            ‚Ä¢ 65-70 years: 12 points<br>
                            ‚Ä¢ 70-75 years: 15 points<br>
                            ‚Ä¢ 75-80 years: 18 points<br>
                            ‚Ä¢ 80-85 years: 21 points<br>
                            ‚Ä¢ 85-90 years: 24 points<br>
                            ‚Ä¢ ‚â•90 years: 27-30 points
                        </td>
                        <td>Advanced age is the strongest predictor of bleeding risk</td>
                    </tr>
                    <tr>
                        <td><strong>Hemoglobin</strong></td>
                        <td>
                            ‚Ä¢ 15.0-18.0 g/dL: 0 points<br>
                            ‚Ä¢ 14.0-15.0 g/dL: 1 point<br>
                            ‚Ä¢ 13.0-14.0 g/dL: 3 points<br>
                            ‚Ä¢ 12.0-13.0 g/dL: 5 points<br>
                            ‚Ä¢ 11.0-12.0 g/dL: 8 points<br>
                            ‚Ä¢ 10.0-11.0 g/dL: 12 points<br>
                            ‚Ä¢ 9.0-10.0 g/dL: 17 points<br>
                            ‚Ä¢ 8.0-9.0 g/dL: 22 points
                        </td>
                        <td>Anemia increases bleeding risk and severity (inverse linear scaling)</td>
                    </tr>
                    <tr>
                        <td><strong>Creatinine Clearance</strong></td>
                        <td>
                            ‚Ä¢ 120-150 mL/min: 0 points<br>
                            ‚Ä¢ 90-120 mL/min: 1 point<br>
                            ‚Ä¢ 75-90 mL/min: 3 points<br>
                            ‚Ä¢ 60-75 mL/min: 6 points<br>
                            ‚Ä¢ 45-60 mL/min: 10 points<br>
                            ‚Ä¢ 30-45 mL/min: 15 points<br>
                            ‚Ä¢ 15-30 mL/min: 21 points
                        </td>
                        <td>Renal dysfunction affects drug clearance and platelet function</td>
                    </tr>
                    <tr>
                        <td><strong>White Blood Cell Count</strong></td>
                        <td>
                            ‚Ä¢ 2.0-4.0 √ó 10‚Åπ/L: 0 points<br>
                            ‚Ä¢ 4.0-6.0 √ó 10‚Åπ/L: 1 point<br>
                            ‚Ä¢ 6.0-8.0 √ó 10‚Åπ/L: 2 points<br>
                            ‚Ä¢ 8.0-10.0 √ó 10‚Åπ/L: 4 points<br>
                            ‚Ä¢ 10.0-12.0 √ó 10‚Åπ/L: 6 points<br>
                            ‚Ä¢ 12.0-15.0 √ó 10‚Åπ/L: 9 points<br>
                            ‚Ä¢ 15.0-20.0 √ó 10‚Åπ/L: 13 points<br>
                            ‚Ä¢ 20.0-25.0 √ó 10‚Åπ/L: 18 points
                        </td>
                        <td>Elevated WBC may indicate systemic inflammation</td>
                    </tr>
                    <tr>
                        <td><strong>Prior Bleeding</strong></td>
                        <td>
                            ‚Ä¢ No: 0 points<br>
                            ‚Ä¢ Yes: 25 points
                        </td>
                        <td>Previous bleeding is a strong predictor of future bleeding</td>
                    </tr>
                </tbody>
            </table>
            
            <h3>Calculation Formula</h3>
            <div class="code-block">
PRECISE-DAPT Score = Age Score + Hemoglobin Score + Creatinine Clearance Score + WBC Score + Prior Bleeding Score

Score Range: 0-100 points
High Risk Threshold: ‚â•25 points

Based on nomogram-derived scoring tables for continuous risk assessment
            </div>
            
            <div class="alert alert-warning">
                <strong>Important:</strong> This implementation uses detailed scoring tables based on the PRECISE-DAPT nomogram, providing more granular risk assessment than simplified categorical scoring.
            </div>
            
            <h3>Risk Stratification</h3>
            <div class="risk-categories">
                <div class="risk-category low-risk">
                    <h3>Low Risk</h3>
                    <p><strong>Score: 0-15</strong></p>
                    <p><strong>Recommendation:</strong> Standard DAPT duration (12 months)</p>
                </div>
                <div class="risk-category moderate-risk">
                    <h3>Moderate Risk</h3>
                    <p><strong>Score: 16-24</strong></p>
                    <p><strong>Recommendation:</strong> Standard DAPT with careful monitoring</p>
                </div>
                <div class="risk-category high-risk">
                    <h3>High Risk</h3>
                    <p><strong>Score: ‚â•25</strong></p>
                    <p><strong>Recommendation:</strong> Consider shorter DAPT (3-6 months)</p>
                </div>
            </div>
        </div>

        <!-- Technical Implementation -->
        <div class="section" id="implementation">
            <h2>‚ö° Technical Implementation</h2>
            
            <h3>Architecture Overview</h3>
            <div class="feature-grid">
                <div class="feature">
                    <strong>Frontend</strong><br>
                    HTML5, CSS3, JavaScript<br>
                    Responsive design
                </div>
                <div class="feature">
                    <strong>Backend</strong><br>
                    Python Flask<br>
                    RESTful APIs
                </div>
                <div class="feature">
                    <strong>FHIR Integration</strong><br>
                    FHIR R4 compliant<br>
                    SMART on FHIR 2.0
                </div>
                <div class="feature">
                    <strong>Security</strong><br>
                    OAuth2 authentication<br>
                    HIPAA compliant
                </div>
            </div>
            
            <h3>Data Sources</h3>
            <table class="score-table">
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>FHIR Resource</th>
                        <th>LOINC Code</th>
                        <th>Extraction Logic</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Age</td>
                        <td>Patient.birthDate</td>
                        <td>N/A</td>
                        <td>Calculate from birth date</td>
                    </tr>
                    <tr>
                        <td>Hemoglobin</td>
                        <td>Observation</td>
                        <td>718-7</td>
                        <td>Most recent value within 30 days</td>
                    </tr>
                    <tr>
                        <td>Creatinine</td>
                        <td>Observation</td>
                        <td>2160-0</td>
                        <td>Calculate CrCl using Cockcroft-Gault</td>
                    </tr>
                    <tr>
                        <td>WBC Count</td>
                        <td>Observation</td>
                        <td>26464-8</td>
                        <td>Most recent value within 30 days</td>
                    </tr>
                    <tr>
                        <td>Prior Bleeding</td>
                        <td>Condition</td>
                        <td>Various</td>
                        <td>Search bleeding-related codes</td>
                    </tr>
                </tbody>
            </table>
            
            <h3>API Endpoints</h3>
            <div class="code-block">
GET /api/calculate_risk
- Returns patient bleeding risk assessment

GET /cds-services
- CDS Hooks service discovery

POST /cds-services/dapt_bleeding_risk_alert
- CDS Hook for medication prescribing
            </div>
            
            <h3>Security & Compliance</h3>
            <ul>
                <li><strong>HIPAA Compliant:</strong> Secure data handling</li>
                <li><strong>No Persistent Storage:</strong> Patient data not retained</li>
                <li><strong>Audit Logging:</strong> Complete access trail</li>
                <li><strong>Encrypted Transport:</strong> HTTPS only</li>
            </ul>
        </div>

        <!-- Support -->
        <div class="section">
            <h2>üìû Support & Contact</h2>
            <div class="feature-grid">
                <div class="feature">
                    <strong>Technical Support</strong><br>
                    Available 24/7<br>
                    Integration assistance
                </div>
                <div class="feature">
                    <strong>Clinical Questions</strong><br>
                    Cardiology team<br>
                    Evidence-based guidance
                </div>
                <div class="feature">
                    <strong>Compatible EHRs</strong><br>
                    Cerner<br>
                    SMART on FHIR enabled
                </div>
                <div class="feature">
                    <strong>Implementation</strong><br>
                    2-4 weeks typical<br>
                    Training provided
                </div>
            </div>
            
            <p style="text-align: center; margin-top: 30px; color: #666;">
                ¬© 2024 PRECISE-DAPT Bleeding Risk Calculator | Version 2.1.0 | 
                <a href="/landing">Landing Page</a> | 
                <a href="/">Launch App</a>
            </p>
        </div>
    </div>

    <script>
        // Smooth scrolling for anchor links
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({
                        behavior: 'smooth',
                        block: 'start'
                    });
                }
            });
        });
    </script>
</body>
</html> 